Here, we assessed whether the divergent metabolic effects of OCs and low-dose PioFluMet or SPIOMET in adolescent girls with PCOS over the first 6 months of treatment associate to changes in circulating follistatin levels. Here, FST is linked to polycystic ovary syndrome.